Hepatitis B vaccination and prevention of hepatocellular carcinoma
Rising prevalence of diabetes and obesity, advancement in drug delivery technologies, and growing focus on preventive healthcare and personalized medicine are major key factors driving the market revenue growth of the GLP-1 Receptor Agonist market
Balancing Risks and Benefits Although gastroparesis is rarely dangerous, its symptoms nausea, constipation, or diarrhea can still affect daily life
Weight Loss Pills Safe for Kidneys: UK Guidance and Options Weight loss pills safe for kidneys are a growing concern for the many people in the UK living with chronic kidney disease (CKD), kidney stones, or other renal conditions who also need to manage their weight
August 1, 2025: People Who Experienced Vision Loss from Trulicity May Have New Legal Options Trulicity and other GLP-1 drugs can put people at an increased risk of a serious eye condition called NAION (non-arteritic anterior ischemic optic neuropathy), which can cause permanent blindness
/SFP-Banner-desktop-Jan26.png)
